Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Idiopathic Pulmonary Fibrosis
In brief
This is a Phase 3 trial to evaluate the efficacy and safety of 30 milligrams (mg)/kilogram (kg) intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in participants with IPF.
Key facts
- Study ID
- NCT03955146
- Run by
- Kyntra Bio
- People needed
- 393
- Starts
- 2019-06-18
- Expected to finish
- 2023-08-28
- Last updated by the study team
- 2024-09-19
Who can join
Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner University Medical Center - Phoenix — Phoenix, Arizona, United States
- Norton Thoracic Institute — Phoenix, Arizona, United States
- Pulmonary Associates, PA - Research — Phoenix, Arizona, United States
- University of Arizona — Tucson, Arizona, United States
- J&L Research — Conway, Arkansas, United States
- Loma Linda University Health — Loma Linda, California, United States
- David Geffen School of Medicine at UCLA — Los Angeles, California, United States
- UC Davis Medical Center — Sacramento, California, United States
- University of California San Diego — San Diego, California, United States
- Stanford University Medical Center — Stanford, California, United States
- University of Colorado Denver — Aurora, Colorado, United States
- National Jewish Health — Denver, Colorado, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- Medstar Georgetown University Hospital — Washington D.C., District of Columbia, United States
- St. Francis Medical Center — Clearwater, Florida, United States
- University of Florida Pulmonary, Critical Care & Sleep Medicine Division — Gainesville, Florida, United States
- University of Florida Health, Jacksonville — Jacksonville, Florida, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Pulmonary Disease Specialist, PA d/b/a, PDS Research — Kissimmee, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Emory University — Atlanta, Georgia, United States
- Piedmont Healthcare, Inc. — Austell, Georgia, United States
- Northwestern University — Chicago, Illinois, United States
- Loyola University of Chicago — Maywood, Illinois, United States
- University of Alabama at Birmingham Hospital — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.